A Hybrid Alloying Nanozyme‐Glutathione Inhibitor Co‐Delivery System Initiates a Dual‐Disruption on Cancer Redox Homeostasis
Small · 2025
DOI: 10.1002/smll.202407555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Jue Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Zhejiang University, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: Oxidation-Reduction, Homeostasis, Glutathione, Alloys. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Altered redox homeostasis has long been observed in cancer cells, which can be exploited for therapeutic benefits. However, reactive oxygen species (ROS) pleiotropy coupling with reductive adaptation in cancer cells poses a formidable challenge for redox dyshomeostasis‐based cancer therapy. Herein, a AuPd alloying nanozyme‐glutathione (GSH) biosynthesis inhibitor co‐delivery system (B‐BMES) is developed using dendritic SiO 2 as a matrix to target cancer redox homeostasis. By optimizing element composition, the alloying nanozyme in B‐BMES exhibits a potent peroxidase (POD)‐like activity to trigger ROS insults‐mediated redox dyshomeostasis. Such a POD functionality is attributed to the optimized electronic structure and catalytic activity. Simultaneously, the B‐BMES abrogates the reductive adaptation by exerting its molecule‐targeted GSH suppression, thereby achieving a dual‐disruption on cancer redox homeostasis. Camouflaging B‐BMES with tumor‐homologous cytomembrane, a hybrid nanosystem with biological stability and tumor‐targeting ability is further fabricated, which initiates a safe, precise redox disruption‐based cancer therapy and sensibilizes standard chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Zhejiang University, Hangzhou, 310058, China.
- Department of Radiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, China.
ORCID-Profile: Hongzhen Bai
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Hou, J., Bao, H., Wang, Y., Zhou, Q., Chen, J., Pan, G., Xu, G., Zhang, J., Tang, G., & Bai, H. (2025). A Hybrid Alloying Nanozyme‐Glutathione Inhibitor Co‐Delivery System Initiates a Dual‐Disruption on Cancer Redox Homeostasis. Small. https://doi.org/10.1002/smll.202407555
Vancouver
Hou J, Bao H, Wang Y, Zhou Q, Chen J, Pan G, et al. A Hybrid Alloying Nanozyme‐Glutathione Inhibitor Co‐Delivery System Initiates a Dual‐Disruption on Cancer Redox Homeostasis. Small. 2025. doi:10.1002/smll.202407555
BibTeX
@article{Hou2025,
author = {Hou, Jue and Bao, Hanxiao and Wang, Yu and Zhou, Qiaomei and Chen, Jiayi and Pan, Guohua and Xu, Guoqiao and Zhang, Jinguo and Tang, Guping and Bai, Hongzhen},
title = {A Hybrid Alloying Nanozyme‐Glutathione Inhibitor Co‐Delivery System Initiates a Dual‐Disruption on Cancer Redox Homeostasis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202407555}
}
EUVIMED